Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

Clinical trial NCT00402428 · COMPLETED

Trial details

NCT number: NCT00402428
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2006-12-01
Primary completion: 2009-02-01
Enrollment: 1331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.